FIELD: chemistry.
SUBSTANCE: described are novel triazole derivatives with general formula where values of radicals are given in the formula of invention, a pharmaceutical composition containing said derivatives, and a method of treating autoimmune diseases. Compounds with general formula (1) and their pharmaceutically acceptable salts have inhibition effect on S1P and its Edg-1 receptor (S1P1).
EFFECT: possibility of use as a pharmaceutical product.
43 cl, 10 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
NOVEL ANTICONVULSIVE SUBSTITUTED SULFAMATE DERIVATIVES | 2003 |
|
RU2328502C2 |
MECHANOCHEMICAL METHOD FOR THE SYNTHESIS OF COUMARINS | 2022 |
|
RU2799566C1 |
NOVEL COMPOUNDS AND USE THEREOF IN THERAPY | 2004 |
|
RU2412190C2 |
USE OF EP4 RECEPTOR ANTAGONIST IN TREATMENT OF CARTILAGE DISEASE | 2014 |
|
RU2663620C2 |
PYRAZOLE DERIVATIVES APPLIED AS PROTEIN KINASE INHIBITORS | 2001 |
|
RU2340611C2 |
DIHYDROBENZODIAZEPINES, METHODS FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2247115C2 |
PYRAZOLE DERIVATIVES APPLICABLE AS PROTEIN KINASE INHIBITORS | 2001 |
|
RU2355688C2 |
PYRAZOLE DERIVATIVES, USEFUL AS INHIBITORS OF PROTEIN KINASE | 2001 |
|
RU2332415C2 |
METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTIONS | 2012 |
|
RU2665021C2 |
METHODS AND COMPOSITIONS TO IMPROVE COGNITIVE FUNCTIONS | 2012 |
|
RU2792010C2 |
Authors
Dates
2010-03-10—Published
2005-08-04—Filed